SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-034720
Filing Date
2019-09-13
Accepted
2019-09-13 16:34:01
Documents
5
Effectiveness Date
2019-09-13

Document Format Files

Seq Description Document Type Size
1 S-8 - INDUCEMENT PLAN xene-s8.htm S-8 165880
2 EX-5.1 xene-ex51_6.htm EX-5.1 9217
3 EX-23.1 xene-ex231_7.htm EX-23.1 19721
4 GRAPHIC g2k5qlq4xsab000001.jpg GRAPHIC 2469
5 GRAPHIC g45ktemob55c000001.jpg GRAPHIC 4652
  Complete submission text file 0001564590-19-034720.txt   205917
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233758 | Film No.: 191092926
SIC: 2834 Pharmaceutical Preparations